$BCAP Baron Capital To Maintain Current Share Structure

New Post Public Reply Private Reply Replies (0) Message Board
equijohn

$BCAP

Baron Capital To Maintain Current Share Structure For 2 Years

 

AND WILL NOT EFFECT A REVERSE SPLIT ON THE COMMON STOCK FOR TWO YEARS


FT. LAUDERDALE, Fla., June 5, 2012 /PRNewswire via COMTEX/ -- Baron Capital Enterprises, Inc. (OTCPK: BCAP) ( www.baroncapitalenterprise.com ) is pleased to announce that the Company will be completing a mailing to all shareholders by the end of the month requesting them to vote on a resolution stating the current share structure shall remain the same for two years and the Company will not effect a reverse split during this period.

The Company intends to file Restated Articles with the State of Florida showing the Company has Authorized Common Stock of 2.4 Billion and 5 Million Authorized shares of Preferred Stock. The Company has received approval from the Preferred control group, but would like the Common shareholders to participate in the vote as well. The Company has already received approval from over 40% of the Common shareholders.

This will ensure the Company does not increase the Authorized shares of the Common stock for two years and does not create any other class of stock that could convert into the Common stock for two years. This will also give shareholders peace of mind that the Company will not effect any type of reverse split during the same period.

In other news:

The Company has narrowed its search for its new headquarters to two buildings and plans to announce its new home in a few weeks. Each building is a class A office building that will build out the new office suite to our specifications. This will be the new headquarters of the Company for 5 years. Our anticipated move-in time is the end of July to the beginning of August.

The audit process is moving along and further updates will be available shortly.

The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact:

Matt Dwyer, President matt@bcapent.com 954-623-3209

SOURCE Baron Capital Enterprises, Inc.

 

 

  www.prnewswire.com  
 
 Copyright (C) 2012 PR Newswire. All rights reserved
 
EJstocks.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 5

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Growing Asthma Treatment Market Approaches 32 Billion USD

Updated Category News Views 77

Asthma Treatment Market Overview The global asthma treatment market is experiencing significant growth, driven primarily by an alarming increase in asthma cases worldwide. Numerous factors, such as the rise in smoking rates and escalating air pollution levels, contribute to deteriorating lung function, leading to higher asthma incidence. Additionally, awareness campaigns...

Continue Reading
Important Update for NET Power, Inc. (NPWR) Shareholders

Updated Category News Views 309

Significant Information for NET Power, Inc. Investors NET Power, Inc. is a notable player in the energy sector, focusing on innovative solutions to improve energy production efficiency. Shareholders of this company may want to pay attention to an ongoing class action lawsuit that has come to light, which aims to recover losses for investors affected by alleged securities...

Continue Reading
TWFG, Inc. Expands Insurance Services with New Acquisition

Updated Category News Views 214

TWFG, Inc. Strengthens Its Insurance Presence TWFG, Inc. (NASDAQ: TWFG), based in The Woodlands, Texas, is proudly expanding its reach. With an exciting acquisition of Alabama Insurance Agency, Inc. and its associated 20 locations, TWFG significantly boosts its footprint in the Southeastern United States. This move not only solidifies their market presence but also...

Continue Reading
Canadian Physician Consensus: Urgent Need for AI Regulations

Updated Category News Views 74

The Call for AI Regulation Among Canadian Physicians Recent findings from a comprehensive study indicate a strong consensus among Canadian healthcare professionals regarding the urgent need for regulation of artificial intelligence (AI) in medical practice. This striking development underscores the increasing influence of AI in healthcare and the responsibility of...

Continue Reading
Bristol Myers Squibb's New Approach in Alzheimer's Drug Study

Updated Category News Views 220

Bristol Myers Squibb Expands Alzheimer’s Study After Irregularities Bristol Myers Squibb & Co (NYSE: BMY) recently announced it will be increasing patient enrollment in the ADEPT-2 Phase 3 study. This decision comes in light of unexpected irregularities identified in the study's execution across certain clinical trial sites. Understanding the ADEPT-2 Study The ADEPT-2...

Continue Reading